C4 Therapeutics
CCCC
CCCC
124 hedge funds and large institutions have $905M invested in C4 Therapeutics in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 47 increasing their positions, 32 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.76% more ownership
Funds ownership: 73.81% → 76.58% (+2.8%)
22% less capital invested
Capital invested by funds: $1.15B → $905M (-$249M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
124
Holding in Top 10
1
Calls
$13.1M
Puts
$5.3M
Top Buyers
| 1 | +$49.4M | |
| 2 | +$15.5M | |
| 3 | +$14.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$12.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.1M |
Top Sellers
| 1 | -$44.4M | |
| 2 | -$32.1M | |
| 3 | -$18.7M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$9.57M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$7.9M |